Vir Biotechnology

(NASDAQ) VIR

Current Price$10.00

Market Cap$1.61B

Since IPO (2019)-29%

5 Year-79%

1 Year+64%

1 Month+11%

Vir Biotechnology Financials at a Glance

Market Cap

$1.61B

Revenue (TTM)

$68.56M

Net Income (TTM)

$437.99M

EPS (TTM)

$-3.16

P/E Ratio

-3.16

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$10.00

Volume

1,050,633.032

Open

$10.22

Price

$10.00

Volume

1,050,633.032

Open

$10.22

Previous Close

$10.00

Daily Range

$9.94 - $10.43

52-Week Range

$4.16 - $11.66

Dividend

$0.00

Beta (Volatility)

1.33 (Average)

Price

$10.00

Volume

1,050,633.032

Open

$10.22

Previous Close

$10.00

Daily Range

$9.94 - $10.43

52-Week Range

$4.16 - $11.66

VIR News

Page 1

VIR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vir Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

367

CEO

Marianne de Backer, PhD, MBA

Website

www.vir.bio

Headquarters

San Francisco, CA 94158, US

VIR Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-7%

Net Income Margin

-6%

Return on Equity

-46%

Return on Capital

-51%

Return on Assets

-44%

Earnings Yield

-31.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.61B

Shares Outstanding

161.23M

Volume

1.05M

Avg. Volume

3.44M

Financials (TTM)

Gross Profit

$56.85M

Operating Income

$468.02M

EBITDA

$426.09M

Operating Cash Flow

$391.78M

Capital Expenditure

$4.83M

Free Cash Flow

$396.61M

Cash & ST Invst.

$462.86M

Total Debt

$186.91M

Vir Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$64.07M

+417.8%

Gross Profit

$430.63M

+663.5%

Gross Margin

6.72%

N/A

Market Cap

$1.61B

N/A

Market Cap/Employee

$3.95M

N/A

Employees

408

N/A

Net Income

$42.92M

+59.0%

EBITDA

$40.16M

+59.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$275.95M

-65.8%

Accounts Receivable

$3.60M

-29.4%

Inventory

$0.00

N/A

Long Term Debt

$178.11M

+97.6%

Short Term Debt

$8.80M

+13.5%

Return on Assets

-43.68%

N/A

Return on Invested Capital

-51.43%

N/A

Free Cash Flow

$21.39M

+76.2%

Operating Cash Flow

$25.88M

+70.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IOVAIovance Biotherapeutics, Inc.

IOVAIovance Biotherapeutics, Inc.$3.40+1.19%

MRVIMaravai LifeSciences Holdings, Inc.

MRVIMaravai LifeSciences Holdings, Inc.$3.73+1.36%

GERNGeron Corporation

GERNGeron Corporation$1.58+2.60%

DAWNDay One Biopharmaceuticals, Inc.

DAWNDay One Biopharmaceuticals, Inc.$21.53+0.00%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$8.77-0.74%

DNAGinkgo Bioworks Holdings, Inc.

DNAGinkgo Bioworks Holdings, Inc.$9.70+14.66%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.41-3.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About VIR

What is the current price of Vir Biotechnology?

Vir Biotechnology is trading at $10.00 per share.

What is the 52-week range for Vir Biotechnology?

Over the past 52 weeks, Vir Biotechnology has traded between $4.16 and $11.66.

How much debt does Vir Biotechnology have?

As of the most recent reporting period, Vir Biotechnology reported total debt of $97.85M.

How much cash does Vir Biotechnology have on hand?

Vir Biotechnology reported $234.11M in cash and cash equivalents in its most recent financial results.

What is Vir Biotechnology’s dividend yield?

Vir Biotechnology does not currently have a dividend yield.

Vir Biotechnology

Vir Biotechnology Financials at a Glance

VIR News

Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000

Vir (VIR) Q2 Revenue Drops 61%

Is Vir Biotechnology Stock a Buy?

Why Shares of Vir Biotechnology Are Plunging Thursday

2 Stocks That Could Turn $100 Into $1,000 by 2028

2 Fast-Growing Healthcare Stocks to Buy and Hold

Why Vir Biotechnology Jumped Nearly 19% Today

Why Shares of Vir Biotechnology Rose 20.4% This Week

VIR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vir Biotechnology

VIR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vir Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VIR

What is the current price of Vir Biotechnology?

What is the 52-week range for Vir Biotechnology?

How much debt does Vir Biotechnology have?

How much cash does Vir Biotechnology have on hand?

What is Vir Biotechnology’s dividend yield?

Premium Investing Services